This protocol is judged by an institutional evaluation board, an independent group that reviews any scientific trials involving people. If a study includes a Program I drug, after the board approves the protocol as ethical, the scientists have to make an application for an investigational new drug (IND) variety with the FDA.Some researchers and bus